CAD Activators

The chemical class of CAD Activators includes compounds that can indirectly influence CAD function through their effects on apoptosis and DNA damage pathways. CAD is activated during the late stages of apoptosis, particularly in response to apoptotic signals and DNA damage. Compounds such as Staurosporine, Etoposide, Camptothecin, and Doxorubicin are known to induce apoptosis through various mechanisms, including kinase inhibition and DNA damage induction. The initiation of apoptosis by these compounds can lead to the activation of caspases, which in turn activate CAD.

Chemotherapy drugs like Cisplatin and Actinomycin D, as well as microtubule-targeting agents such as Vinblastine and Paclitaxel, can induce apoptosis, potentially leading to the activation of CAD. These compounds induce DNA damage or disrupt cellular structures, triggering apoptotic pathways that involve CAD. Furthermore, natural compounds with apoptotic properties like Sulforaphane, Curcumin, and Resveratrol could also indirectly influence CAD activation. These compounds are known to modulate apoptotic pathways in various cell types, which could lead to the activation of CAD.